In BCC, genetic loss of PTCH1 function or gain of function mutations in SMO results in ligand-independent constitutive HH/GLI signaling and skin carcinogenesis (reviewed in [7]). This evidence concerns the gene GLI1 and skin basal cell carcinoma.